Page 56 - JCBP-3-1
P. 56

Journal of Clinical and
            Basic Psychosomatics                                                  Psychosomatic influences on insomnia



            117. De  la Herrán-Arita AK,  Equihua-Benítez  AC, Drucker-     doi: 10.3389/fpsyg.2019.02466
               Colín R. Treatment of cataplexy. Expert Opin Orphan Drugs.   128. Rodrigues da Silva N, Gomes FV, Sonego AB, da Silva NR,
               2013;1(3):199-210.
                                                                  Guimarães FS. Cannabidiol attenuates behavioral changes in
               doi: 10.1517/21678707.2013.765359                  a rodent model of schizophrenia through 5-HT1A, but not
                                                                  CB  and CB  receptors. Pharmacol Res. 2020;156:104749.
            118. Equihua AC, De La Herrán-Arita AK, Drucker-Colin  R.   1  2
               Orexin receptor antagonists as therapeutic agents for      doi: 10.1016/j.phrs.2020.104749
               insomnia. Front Pharmacol. 2013;4:163.
                                                               129. Hablitz LM, Gunesch AN, Cravetchi O, Moldavan M,
               doi: 10.3389/fphar.2013.00163                      Allen  CN.  Cannabinoid Signaling  recruits  astrocytes to
                                                                  modulate  presynaptic  function  in  the  suprachiasmatic
            119.  De  la  Herrán-Arita  AK,  Equihua-Benítez  AC,
               Drucker-Colín R. Orexin/hypocretin antagonists in   nucleus. eNeuro. 2020;7(1).
               insomnia: From bench to clinic. In:  Milestones in Drug      doi: 10.1523/eneuro.0081-19.2020
               Therapy. Cham: Springer; 2014. p. 191-207.
                                                               130.  Torres-Mondragón  LE,  León-Pimentel  LC,  Pérez-
               doi: 10.1007/978-3-319-11514-6_9                   Tamayo DE, De la Herrán-Arita AK. The endocannabinoid
                                                                  system:  A  new frontier  in  addressing  psychosomatic
            120. De la Herrán-Arita AK, García-García F. Current and
               emerging options for the drug treatment of narcolepsy.   challenges. J Clin Basic Psychosom. 2024;2(1):2288.
               Drugs. 2013;73(16):1771-1781.                      doi: 10.36922/jcbp.2288
               doi: 10.1007/s40265-013-0127-y                  131. Ried K, Tamanna T, Matthews S, Sali A. Medicinal cannabis
                                                                  improves sleep in adults with insomnia: A  randomised
            121.  Osuna-Ramos  JF,    Camberos-Barraza   J,
               Torres-Mondragón  LE,  et al.  Interplay  between  the   double-blind placebo-controlled crossover study. J Sleep Res.
               glymphatic  system  and  the  endocannabinoid  system:   2023;32(3):e13793.
               Implications for brain health and disease.  Int J Mol Sci.      doi: 10.1111/jsr.13793
               2023;24(24):17458-17458.
                                                               132. Xantus G, Zavori L, Matheson  C, Gyarmathy VA,
               doi: 10.3390/ijms242417458                         Fazekas  LM, Kanizsai P. Cannabidiol in low back pain:
                                                                  Scientific rationale for clinical trials in low back pain. Expert
            122. Pérez-Morales M, De La Herrán-Arita AK, Méndez-Díaz M,
               Ruiz-Contreras AE, Drucker-Colín R, Prospéro-García O.   Rev Clin Pharmacol. 2021;14(6):671-675.
               2-AG into the lateral hypothalamus increases REM sleep      doi: 10.1080/17512433.2021.1917379
               and cFos expression in melanin concentrating hormone   133. Namdar D, Koltai H. Medical cannabis for the treatment of
               neurons in rats. Pharmacol Biochem Behav. 2013;108:1-7.
                                                                  inflammation. Nat Prod Commun. 2018;13(3):249-254.
               doi: 10.1016/j.pbb.2013.04.006
                                                                  doi: 10.1177/1934578x1801300304
            123. Zou  S,  Kumar  U.  Cannabinoid  receptors  and  the   134. Bruni O, Ferini-Strambi L, Giacomoni E, Pellegrino P.
               endocannabinoid system:  Signaling and  function  in the   Herbal remedies and their possible effect on the GABAergic
               central nervous system. Int J Mol Sci. 2018;19(3):833.
                                                                  system and sleep. Nutrients. 2021;13(2):530.
               doi: 10.3390/ijms19030833
                                                                  doi: 10.3390/nu13020530
            124. Low  ZXB,  Lee  XR,  Soga  T,  Goh  BH,  Alex  D,  Kumari  Y.   135. Zeng H, Xu J, Zheng L,  et  al. Traditional Chinese herbal
               Cannabinoids:  Emerging  sleep  modulator.  Biomed   formulas modulate gut microbiome and improve insomnia
               Pharmacother. 2023;165:115102.
                                                                  in patients with distinct syndrome types: Insights from an
               doi: 10.1016/j.biopha.2023.115102                  interventional clinical study.  Front  Cell Infect  Microbiol.
                                                                  2024;14:1395267.
            125. Mechoulam R, Gaoni Y. A  total synthesis of dl-delta-1-
               tetrahydrocannabinol, the active constituent of hashish.      doi: 10.3389/fcimb.2024.1395267
               J Am Chem Soc. 1965;87:3273-3275.
                                                               136. Deuel LM, Seeberger LC. Complementary therapies
               doi: 10.1021/ja01092a065                           in parkinson disease: A  review of acupuncture, Tai
                                                                  Chi, Qi Gong, Yoga, and  Cannabis.  Neurotherapeutics.
            126. Glodosky NC, Cuttler C, McLaughlin RJ. A review of the
               effects of acute and chronic cannabinoid exposure on the   2020;17(4):1434-1455.
               stress response. Front Neuroendocrinol. 2021;63:100945.     doi: 10.1007/s13311-020-00900-y
               doi: 10.1016/j.yfrne.2021.100945                137. Li H, Chen J, Xu G, et al. The effect of Tai Chi for improving
                                                                  sleep quality: A systematic review and meta-analysis. J Affect
            127. Masataka N. Anxiolytic effects of repeated cannabidiol
               treatment in teenagers with social anxiety disorders. Front   Disord. 2020;274:1102-1112.
               Psychol. 2019;10:2466.                             doi: 10.1016/j.jad.2020.05.076


            Volume 3 Issue 1 (2025)                         50                              doi: 10.36922/jcbp.4588
   51   52   53   54   55   56   57   58   59   60   61